Parnax Lab Ltd. benchmarking: Perfomance to industry peers

Financial

	Parnax Lab	Kimia Biosciences	Quest Laboratories
Operational Metrics
Financials
5 yr Average ROE	11.43 %	-335.15 %	27.48 %
5yr average Equity Multiplier	2.74	66.02	2.66
5yr Average Asset Turnover Ratio	1.01	1.14	1.38
5yr Avg Net Profit Margin	4.21 %	-0.67 %	8.5 %
Price to Book	1.46	12.0	1.57
P/E	11.91	14.51	10.39
5yr Avg Cash Conversion Cycle	30.1 Days	-33.97 Days	100.68 Days
Inventory Days	45.64 Days	101.63 Days	35.64 Days
Days Receivable	61.56 Days	98.68 Days	95.62 Days
Days Payable	72.37 Days	171.28 Days	124.41 Days
5yr Average Interest Coverage Ratio	2.99	0.78	15.83
5yr Avg ROCE	17.86 %	10.6 %	36.4 %
5yr Avg Operating Profit Margin	13.13 %	3.89 %	12.5 %
5 yr average Debt to Equity	1.12	29.85	0.33
5yr CAGR Net Profit	n/a	13.51 %	83.07 %
5yr Average Return on Assets	4.42 %	-0.69 %	10.79 %
Shareholdings
Promoter Holding	72.3 %	74.94 %	66.78 %
Share Pledged by Promoters	9.41 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.95 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Parnax Lab	Kimia Biosciences	Quest Laboratories
Product Wise Break-Up	Product Wise Break-Up Pharmaceuticals 100.0	Product Wise Break-Up Pharmaceutical 100.0	Product Wise Break-Up Pharmaceuticals 100.0